Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05901272 · ClinicalTrials.gov registry record · NA
Implementation of Collaborative Care for Depression in VA HIV Clinics
A NA study of Depression and HIV, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT05901272: Active NA study of Depression and HIV, sponsored by VA Office of Research and Development.
NCT05901272 is a NA study of Depression and HIV that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 8 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05901272, a NA study of Depression and HIV, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
HIV Translating Initiatives for Depression into Effective Solutions (HITIDES) is a team-based service to manage depression in Veterans Living with HIV (VLWH). This service is more effective for managing depression than the care VLWH usually receive and saves resources. HITIDES is also liked by HIV care providers and VLWH. Despite this, no VA clinics currently offer this service. This study examines two approaches to engage clinics with HITIDES, the resulting effects on VLWH, and the costs of these approaches. The first approach includes recruiting an HIV care provider at the site to help connect with the service and a network of providers to support this person. The second approach uses an additional external expert to facilitate these connections. Understanding how to connect Veterans to the HITIDES service will allow VA to improve depression care for VLWH and save VA resources.
Primary Outcome
Reach. Reach will be calculated as a proportion of eligible patients receiving the intervention at 12 months. The primary comparison of interest, and the one on which the study is powered, is the comparison of reach at 12 months in Arm 1 vs. Arm 2.
Conditions Studied
Interventions
- OTHER Local clinical champion
- OTHER Learning collaborative
- OTHER External facilitation
Study Locations (1)
Arkansas
- Central Arkansas Veterans Healthcare System , Little Rock, AR - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What the registry record for NCT05901272 still lists
NCT05901272 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Local clinical champion is the first listed.
NCT05901272 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT05901272 about?
NCT05901272 is a clinical study titled "Implementation of Collaborative Care for Depression in VA HIV Clinics". HIV Translating Initiatives for Depression into Effective Solutions (HITIDES) is a team-based service to manage depression in Veterans Living with HIV (VLWH). This service is more effective for managing depression than the care VLWH usually receive and saves resources. HITIDES is also liked by HIV c...
What is the current status of trial NCT05901272?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2024-08-01. Estimated completion is 2027-07-31.
What conditions does trial NCT05901272 study?
This clinical trial studies the following conditions: Depression, HIV.
What interventions are being tested in trial NCT05901272?
The interventions under investigation include: Local clinical champion (OTHER), Learning collaborative (OTHER), External facilitation (OTHER).
Who is sponsoring clinical trial NCT05901272?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05901272 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05901272's enrollment target sits among peer trials
8 667th of 679 higher than 10 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy